Living With Squamous Cell Lung Cancer: A Guide for Patients
This booklet provides patients and their caregivers with specific information on squamous cell lung cancer, with a focus on the advanced stage of this cancer. The booklet includes answers to commonly asked questions relating to this disease, including its diagnosis, symptoms, and treatment options, as well aslisting additional sources of help, information, and support.
The booklet has been developed and reviewed by medical experts who treat patients with lung cancer. The content has also been reviewed by patient advocacy groups to ensure it provides patients and their families with the information that they need. The booklet has been endorsed by the International Association for the Study of Lung Cancer and the International Thoracic Oncology Nursing Forum.
Information presented in Living with squamous cell lung cancer: A guide for patients is not intended as a substitute for the advice given by your health-care provider. Lilly provided funding for the development of this booklet.
Founded on Twitter, the #LCSM community fosters social media collaboration among lung cancer patients, caregivers, family members, advocates, healthcare providers, researchers and charities. Its focus is to use social media in an
innovative manner to educate, develop public support, end the stigma, and facilitate successful treatments for the leading cause of cancer deaths worldwide.
Roundtable of Lung Cancer Experts Discuss Taking Ownership of Cancer Treatment at WCLC 2015
Lung cancer is making swift strides in both research and clinical care. What's next? Listen as five lung cancer experts: IASLC President Dr. David Carbone (U.S.), Dr. Fiona Blackhall (UK), Dr. Paul Paik (U.S.), Dr. Rohit Lal (UK), and U.S. patient advocate Chris Draft—offer a global perspective in a deep and honest roundtable discussion that took place during the 16th World Conference on Lung Cancer hosted by the IASLC in Denver.
Lung Cancer Patients/Survivors: Free Attendance to the World Conference 2016 in Vienna December 4-7
WCLC 2016: Patient Advocacy Travel Awards
Patient advocates and advocacy organizations can now apply for the International Association for the Study of Lung Cancer (IASLC) Patient Advocacy Awards, which award free registration and travel expenses to up to five patient advocates for the IASLC 17th World Conference on Lung Cancer (WCLC) held December 4-7, 2016 in Vienna, Austria. The WCLC brings together many leading experts from across the globe to share best practices and the latest developments in lung cancer at the world’s largest meeting dedicated to lung cancer and other thoracic malignancies.
IASLC created the Patient Advocacy Awards in 2011 to improve relationships from the bench to the bedside, creating new links with patient advocates and advocacy organizations. Funding is provided by Bristol-Myers Squibb and includes conference registration, hotel accommodations, travel stipend and complimentary IASLC membership for one year.
Patient Resource Lung Cancer Guide
IASLC partnered with Patient Resource Publishing to produce the 2013 Patient Resource Lung Cancer Guide. This publication provides lung cancer patients and their loved ones with the details they need upon diagnosis. The guide is published in partnership with the International Association for the Study of Lung Cancer and all content has been thoroughly reviewed by medical experts who treat lung cancer patients. The information includes details regarding treatment options, staging & pathology, symptom & side effect management and the many advocacy and financial resources available. Information presented in Patient Resource Cancer Guide: Lung Cancer is not intended as a substitute for the advice given by your health care provider.
National Comprehensive Cancer Network® Resources for Patients
The National Comprehensive Cancer Network® (NCCN®) aims to provide people with cancer and the general public with state-of-the-art cancer treatment information in easy-to-understand language. The NCCN Guidelines for Patients®, translations of the NCCN clinical guidelines, are meant to help patients with cancer talk with their physicians about the best treatment options for their disease. They offer resources for non-small cell lung cancer, malignant pleural mesothelioma, and lung cancer screening. NCCN Guidelines for Patients® do not replace the expertise and clinical judgment of the physician.
Mesothelioma Applied® Research Foundation
The Mesothelioma Applied Research Foundation is the only 501(c)3 non-profit organization dedicated to eradicating mesothelioma and easing the suffering caused by this cancer. The Meso Foundation funds peer-reviewed mesothelioma research; provides patient support services and education; and advocates Congress for increased federal funding for mesothelioma research.
Some of the resources available through its patient support and education services include: one-on-one medical consultations; financial support for patients in need; support groups; conferences for patients and their families; brochures about mesothelioma; a clinical trials booklet; a peer support system.